Skip to content
Patients
HCPs
X-twitter Instagram Youtube Icon-mail Tiktok
Follow on X
Home
Daily Updates

Categories

The versatile interplay between steatotic liver disease and liver cancer.

  • Post category:Digestive (CRC, Stomach) System
  • Reading time:3 mins read

This article is a narrative review of how steatotic liver diseases drive hepatocarcinogenesis and how this should inform...

Continue ReadingThe versatile interplay between steatotic liver disease and liver cancer.

Hand-foot skin reaction as a positive prognostic factor in vascular endothelial growth factor receptor-tyrosine kinase inhibitor treatment.

  • Post category:Digestive (CRC, Stomach) System
  • Reading time:2 mins read

This systematic review and meta‑analysis evaluated whether hand–foot skin reaction (HFSR) during treatment with VEGF...

Continue ReadingHand-foot skin reaction as a positive prognostic factor in vascular endothelial growth factor receptor-tyrosine kinase inhibitor treatment.

Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

  • Post category:Hematologic Cancers
  • Reading time:1 min read

Phase 3 EMN24 IsKia trial: transplant-eligible newly diagnosed multiple myeloma (≤70 years) Design - 302 patients r...

Continue ReadingIsatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

CT and MRI LI-RADS Treatment Response Assessment 2024: Core Concepts for Clinical Practice.

  • Post category:Digestive (CRC, Stomach) System
  • Reading time:2 mins read

This article reviews the updated 2024 CT/MRI LI-RADS treatment response (TR) algorithm for patients with hepatocellular...

Continue ReadingCT and MRI LI-RADS Treatment Response Assessment 2024: Core Concepts for Clinical Practice.

Systemic Therapy for Advanced Hepatocellular Carcinoma in 2026: Current Standard-of-Care and Emerging Therapeutic Strategies.

  • Post category:Digestive (CRC, Stomach) System
  • Reading time:2 mins read

This review article outlines current and emerging systemic and locoregional treatment strategies for advanced hepatocell...

Continue ReadingSystemic Therapy for Advanced Hepatocellular Carcinoma in 2026: Current Standard-of-Care and Emerging Therapeutic Strategies.

Machine learning predicts hepatocellular carcinoma risk from routine clinical data: a large population-based multicentric study.

  • Post category:Digestive (CRC, Stomach) System
  • Reading time:1 min read

This study developed and validated PRE-Screen-HCC, an interpretable machine-learning framework to stratify hepatocellula...

Continue ReadingMachine learning predicts hepatocellular carcinoma risk from routine clinical data: a large population-based multicentric study.
  • © Together4Cancer. All rights reserved.
  • Privacy Policy
  • Terms of Use